(A and C) Weight gain during HFD feeding from 5 to 13 weeks of age. (B and D) Glucose tolerance test was carried out after 4 weeks of HFD feeding at age 9 weeks. (E–H) Representative hypothalamic sections of age-matched (8 weeks) male nestin-Cre;EpoRWT/WT and nestin-Cre;EpoRloxP/loxP mice after 3 weeks of HFD feeding stained for the nuclear marker, DAPI; inflammatory marker, TNF-α; microglial cell marker, Iba1 (E). (F and G) Quantification was done for TNF-α+ and Ibal1+ cells. (H) Representative fields of view in HFD-fed male nestin-Cre;EpoRWT/WT and nestin-Cre;EpoRloxP/loxP mice, analyzed for quantification of fluorescence intensity of Iba1. (I–J) Male nestin-Cre;EpoRWT/WT and nestin-Cre;EpoRloxP/loxP mice after 3 weeks of HFD feeding were also stained for activated microglial cell markers, CD68 and DAPI, in the MBH, and (I) representative images are shown. (J) Quantification was done for CD68+ cells. (K and L) Representative images from CD169 and P2Y12 staining of hypothalamic sections from male nestin-Cre;EpoRWT/WT and nestin-Cre;EpoRloxP/loxP mice after 3 weeks of HFD feeding, and visualization of boxed areas without DAPI staining and arrowheads pointing to CD169+ cells (K). Quantitative analysis results of P2Y12+ and CD169+ cells (L). Scale bar: 20 μm (H); 100 μm (E, I, and K). Original magnification, ×40 (except in H, ×80). 3V, third ventricle. Each image is representative of n = 8–10/group. For line graph, each data point represents mean ± SD. In box-and-whisker plots, bounds denote the 25th to 75th percentile, the lines represent the medians, and whiskers indicate the range from minimum to maximum values and includes outliers. *P < 0.05, **P < 0.01, ***P < 0.001 (2-way ANOVA).